Huntington National Bank grew its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 32.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 592 shares of the medical device company’s stock after purchasing an additional 144 shares during […]
Bedell Frazier Investment Counseling LLC purchased a new position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,000 shares of the medical device company’s stock, valued at approximately $226,000. A number of other […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) was the target of a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 12,730,000 shares, a growth of 5.4% from the April 15th total of 12,080,000 shares. Based on an average daily volume of 2,350,000 shares, the days-to-cover […]
Cambridge Investment Research Advisors Inc. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 16.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,280 shares of the medical device company’s stock after acquiring an additional 3,656 shares during the […]
EFG Asset Management Americas Corp. lessened its stake in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 9.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,168 shares of the medical device company’s stock after selling 444 shares during the period. […]